Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Little

Showing results (51-60 of 185) with videos related to

Pageof 19
Sort By:
Journal of Cell Communication and Signaling|July 11, 2019
Mechanisms of PAR-1 mediated kinase receptor transactivation: Smad linker region phosphorylationDanielle Kamato, Hang Ta, Rizwana Afroz, et al.
International Journal of Biological Sciences|August 16, 2017
FOXO Signaling Pathways as Therapeutic Targets in CancerMohd Farhan, Haitao Wang, Uma Gaur, et al.
European Journal of Pharmacology|October 13, 2009
Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cellsRobel Getachew, Mandy L Ballinger, Micah L Burch, et al.
Cellular and Molecular Life Sciences : CMLS|November 6, 2012
LOX-1 in atherosclerosis: biological functions and pharmacological modifiersSuowen Xu, Sayoko Ogura, Jiawei Chen, et al.
Research (Washington, D.C.)|August 21, 2025
Emerging Roles of GDF15 in Metabolic and Cardiovascular DiseasesTian Tian, Monan Liu, Peter J Little, et al.
Acta Pharmaceutica Sinica. B|January 14, 2025
Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in <i>ApoE</i> <sup>-/-</sup> miceMeijie Chen, Peter J Little, Sudong Kong, et al.
International Journal of Biological Sciences|October 20, 2022
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapiesTingyu Fang, Hua Wang, Xiaoyue Pan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2002
Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLsPeter J Little, Lisa Tannock, Katherine L Olin, et al.
Molecular and Cellular Endocrinology|March 3, 2017
Role of brain-derived neurotrophic factor and nerve growth factor in the regulation of Neuropeptide W in vitro and in vivoRikang Wang, Fengxia Yan, Rifang Liao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2017
Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetesMd Asrafuzzaman, Yingnan Cao, Rizwana Afroz, et al.
Pageof 19

Showing results (51-60 of 185) with videos related to

Sort By:
Pageof 19
Journal of Cell Communication and Signaling|July 11, 2019
Mechanisms of PAR-1 mediated kinase receptor transactivation: Smad linker region phosphorylationDanielle Kamato, Hang Ta, Rizwana Afroz, et al.
International Journal of Biological Sciences|August 16, 2017
FOXO Signaling Pathways as Therapeutic Targets in CancerMohd Farhan, Haitao Wang, Uma Gaur, et al.
European Journal of Pharmacology|October 13, 2009
Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cellsRobel Getachew, Mandy L Ballinger, Micah L Burch, et al.
Cellular and Molecular Life Sciences : CMLS|November 6, 2012
LOX-1 in atherosclerosis: biological functions and pharmacological modifiersSuowen Xu, Sayoko Ogura, Jiawei Chen, et al.
Research (Washington, D.C.)|August 21, 2025
Emerging Roles of GDF15 in Metabolic and Cardiovascular DiseasesTian Tian, Monan Liu, Peter J Little, et al.
Acta Pharmaceutica Sinica. B|January 14, 2025
Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in <i>ApoE</i> <sup>-/-</sup> miceMeijie Chen, Peter J Little, Sudong Kong, et al.
International Journal of Biological Sciences|October 20, 2022
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapiesTingyu Fang, Hua Wang, Xiaoyue Pan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2002
Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLsPeter J Little, Lisa Tannock, Katherine L Olin, et al.
Molecular and Cellular Endocrinology|March 3, 2017
Role of brain-derived neurotrophic factor and nerve growth factor in the regulation of Neuropeptide W in vitro and in vivoRikang Wang, Fengxia Yan, Rifang Liao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2017
Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetesMd Asrafuzzaman, Yingnan Cao, Rizwana Afroz, et al.
Pageof 19